companies: 6,640     total market cap: $100.7 T
Cadrenal Therapeutics, Inc. Common Stock
CVKD

$24.05 M
Marketcap
$14.50
Share price
US
Country
$-0.13
Change (1 day)
$32.55
Year High
$5.40
Year Low
Biotechnology
Categories

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

marketcap

Stock price history for Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Highest end of day price: $61.80 USD on 2023-01-20

Lowest end of day price: $5.85 USD on 2024-04-16

Stock price history of Cadrenal Therapeutics, Inc. Common Stock from 2023 to 2024


What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

Stock prices are delayed, the delay can range from a few minutes to several hours. MarketCap.tools is not a Financial institution.

Contact

For inquiries or if you want to report a problem write to web@marketcap.tools

© 2023 Marketcap.tools